|
" Association of chemosensory dysfunction and COVID-19 in patients presenting with influenza-like symptoms. "
Yan, Carol H; Faraji, Farhoud; Prajapati, Divya P; Boone, Christine E; DeConde, Adam S
| Document Type
|
:
|
AL
|
| Record Number
|
:
|
911032
|
| Doc. No
|
:
|
LA9kg5g7r0
|
| Title & Author
|
:
|
Association of chemosensory dysfunction and COVID-19 in patients presenting with influenza-like symptoms. [Article]\ Yan, Carol H; Faraji, Farhoud; Prajapati, Divya P; Boone, Christine E; DeConde, Adam S
|
| Date
|
:
|
2020
|
| Title of Periodical
|
:
|
UC San Diego
|
| Abstract
|
:
|
BACKGROUND:Rapid spread of the severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) and concern for viral transmission by ambulatory patients with minimal to no symptoms underline the importance of identifying early or subclinical symptoms of coronavirus disease 2019 (COVID-19) infection. Two such candidate symptoms include anecdotally reported loss of smell and taste. Understanding the timing and association of smell/taste loss in COVID-19 may help facilitate screening and early isolation of cases. METHODS:A single-institution, cross-sectional study evaluating patient-reported symptoms with a focus on smell and taste was conducted using an internet-based platform on adult subjects who underwent testing for COVID-19. Logistic regression was employed to identify symptoms associated with COVID-19 positivity. RESULTS:A total of 1480 patients with influenza-like symptoms underwent COVID-19 testing between March 3, 2020, and March 29, 2020. Our study captured 59 of 102 (58%) COVID-19-positive patients and 203 of 1378 (15%) COVID-19-negative patients. Smell and taste loss were reported in 68% (40/59) and 71% (42/59) of COVID-19-positive subjects, respectively, compared to 16% (33/203) and 17% (35/203) of COVID-19-negative patients (p < 0.001). Smell and taste impairment were independently and strongly associated with COVID-19 positivity (anosmia: adjusted odds ratio [aOR] 10.9; 95% CI, 5.08-23.5; ageusia: aOR 10.2; 95% CI, 4.74-22.1), whereas sore throat was associated with COVID-19 negativity (aOR 0.23; 95% CI, 0.11-0.50). Of patients who reported COVID-19-associated loss of smell, 74% (28/38) reported resolution of anosmia with clinical resolution of illness. CONCLUSION:In ambulatory individuals with influenza-like symptoms, chemosensory dysfunction was strongly associated with COVID-19 infection and should be considered when screening symptoms. Most will recover chemosensory function within weeks, paralleling resolution of other disease-related symptoms.
|
| |